CNC vs MRKR · P/E 8.4, rev $103.52B vs rev $751.7K
Centene Corp (CNC) versus Marker Therapeutics Inc (MRKR) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. MRKR currently screens at market cap $25.3M.
Not investment advice. Open the CNC and MRKR stock pages for the full models.
Not investment advice.